← Back to Search

Kind Minds Program for Youth Anxiety and Depression (KMP Trial)

N/A
Recruiting
Led By Denise A Chavira, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Parent and youth must have a smart phone and be willing to download the online mindfulness program
Participants will include one adolescent (aged 12-17 years) with a current diagnosis of an anxiety or depressive disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-14 weeks after baseline assessment
Awards & highlights

KMP Trial Summary

This trial will explore whether having both an adolescent and their parent/caregiver participate in a mindfulness intervention together has additive effects on the adolescent's mental health symptoms, compared to when only the adolescent participates.

Who is the study for?
This trial is for teens aged 12-17 with anxiety or depression and their parents/caregivers. Both must speak English well enough to use an English-only digital mindfulness program, have a smartphone, and agree to download the program. They can't join if they're already receiving mindfulness therapy, taking certain medications, or have specific mental health conditions like bipolar disorder or autism.Check my eligibility
What is being tested?
The Kind Minds Program is being tested to see if it helps reduce symptoms of anxiety and depression in youth when both the teen and parent practice mindfulness together. The study compares outcomes between families where only the teen participates versus those where both teen and parent engage in the 9-week online program.See study design
What are the potential side effects?
Since this intervention involves a non-invasive mindfulness program, significant side effects are not anticipated. However, participants may experience emotional discomfort while reflecting on personal thoughts during mindfulness practices.

KMP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child and I both have smartphones and are willing to download a mindfulness app.
Select...
I am aged 12-17 and diagnosed with anxiety or depression.
Select...
I am between 12-17 years old and have been diagnosed with anxiety or depression.
Select...
Both I and my caregiver can speak English well enough to join an English-only program.
Select...
Both I and my caregiver can speak English well enough to join an English-only program.
Select...
My child and I both have smartphones and are willing to download a mindfulness app.

KMP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-14 weeks after baseline assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-14 weeks after baseline assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Generalized Anxiety Disorder-7
Patient Health Questionnaire-9
Anxiety
Secondary outcome measures
Kiddie Schedule for Affective Disorders and Schizophrenia interview -anxiety and depressive disorder modules

KMP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Kind Minds Program -FamilyExperimental Treatment1 Intervention
In the Family condition (KMP-Fam), both caregiver and adolescent will receive the KMP intervention via an online mindfulness program, augmented by weekly video conference support from a Community Health Worker (CHW) Kindness Coach
Group II: Kind Minds Program -Teen OnlyActive Control1 Intervention
In the Teen-Only condition (KMP-TO), only the adolescent will receive the KMP intervention via an online mindfulness program augmented by weekly video conference support from a CHW Kindness Coach.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,821 Total Patients Enrolled
101 Trials studying Depression
48,413 Patients Enrolled for Depression
Denise A Chavira, PhDPrincipal InvestigatorUniversity of California, Los Angeles
1 Previous Clinical Trials
43 Total Patients Enrolled

Media Library

Kind Minds Program Clinical Trial Eligibility Overview. Trial Name: NCT05353751 — N/A
Depression Research Study Groups: Kind Minds Program -Family, Kind Minds Program -Teen Only
Depression Clinical Trial 2023: Kind Minds Program Highlights & Side Effects. Trial Name: NCT05353751 — N/A
Kind Minds Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05353751 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the criteria for enrolment in this clinical trial?

"In order to join this medical experiment, a participant must be diagnosed with depression and have reached the age of at least 12 but not yet 18. The trial is presently recruiting 30 people in total."

Answered by AI

Are individuals currently being accepted to this research study?

"Clinicaltrials.gov reports that this clinical trial was initiated on May 31st, 2022 and is actively recruiting participants. The last time the study information was modified was October 31st, 2022."

Answered by AI

Is the age range of eligible participants for this research project inclusive of seniors?

"This research project necessitates that participants must be adolescent, aged between 12 to 17. On clinicaltrials.gov there are currently 269 studies seeking minors and 1157 for seniors."

Answered by AI

How many participants is the trial recruiting?

"Affirmative. Information hosted on clinicaltrials.gov testifies that the trial, initiated May 31st 2022, is actively enrolling patients. The research team aims to recruit thirty participants from a single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Alabama
Georgia
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~1 spots leftby Jun 2024